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The influenza B virus NB glycoprotein is abundantly expressed at the surface of virus-infected cells. NB spans the
membrane once and has an 18 amino acid ectodomain, a 22 amino acid transmembrane domain, and a 60 amino acid
cytoplasmic tail. The NB N-terminal ectodomain contains two asparagine residues that are modified by the addition of N-
linked carbohydrate chains, which become further modified by the addition of polylactosaminoglycan. We have now shown
that NB is also modified by addition of palmitic acid. To determine if NB is incorporated into virions, metabolic labeling,
immunoblotting, and immunogold electron microscopy techniques were used. NB was identified in virions grown in MDCK
cells or in embryonated chicken eggs in two forms: (a) NB modified by addition of polylactosaminoglycan (NBpl), and (b) a
cleaved species (NBc) that has a smaller molecular weight than unglycosylated NB (NB12). Proteinase K digestion of purified
virions converted NBpl to NBc . Examination of virions purified by isopycnic centrifugation by electronmicroscopy and
immunogold staining, using an affinity-purified antibody raised to a peptide derived from the NB cytoplasmic tail, showed
staining for NB in influenza B virions. Quantification of the amount of NB in purified virions using two unrelated biochemical
methods indicated there are on average approximately 15–100 molecules of NB per virion. Although the number of NB
molecules incorporated on average into an influenza B virus particle is small, this finding is reminiscent of the number of
molecules (14–68 monomers) found on average of the M2 integral membrane protein of influenza A virus. q 1996 Academic
Press, Inc.
INTRODUCTION A virus also encodes two proteins, M1 and M2 , with the
M1 protein encoded by a collinear mRNA transcript, butInfluenza A and B viruses contain eight negative-
in this case the M2 protein is encoded by a spliced mRNAstranded RNA segments that encode one, or in some
(Lamb et al., 1981). The M2 protein is a type III integralcases, more than one protein. Of the eleven known pro-
membrane protein (Lamb et al., 1985; Zebedee et al.,teins of influenza B virus, nine have a counterpart in
1985) and it has an ion channel activity that is blockedinfluenza A virus: the polymerase-associated proteins
by the antiviral drug amantadine (Pinto et al., 1992;PB1, PB2, and PA, the hemagglutinin (HA), the neuramini-
Sugrue and Hay, 1991; reviewed in Lamb et al., 1994).dase (NA), the nucleocapsid protein (NP), the matrix pro-
Another major difference between the influenza A and Btein (M1), and two proteins NS1 and NS2 , the function of virus is found with RNA segment 6. Whereas influenzawhich are not fully understood. NS1 appears to be in- A virus RNA segment 6 only encodes NA, influenza Bvolved in the transport of mRNAs from the nucleus (Qian
virus RNA segment 6 encodes two integral membraneet al., 1994; Qiu and Krug, 1994; reviewed in Lamb and
proteins NB and NA using a bicistronic mRNA containingKrug, 1996).
overlapping reading frames. The AUG initiation codonsOne major difference between influenza A and B vi-
for NB and NA are separated by four nucleotides (Shawruses concerns both the coding strategy and nature of
et al., 1983, 1982; Williams and Lamb, 1986).the proteins encoded by RNA segment 7. Influenza B
The NB glycoprotein is a type III integral membranevirus RNA segment 7 contains two cistrons in tandem
protein of 100 amino acid residues with an 18-residuethat encode the M1 and BM2 proteins (Briedis et al., 1982;
N-terminal extracellular domain, a 22-residue transmem-Hiebert et al., 1986; Horvath et al., 1990). The available
brane domain, and a 60-residue cytoplasmic tail (Shawevidence indicates the BM2 protein is synthesized by a
et al., 1983; Williams and Lamb, 1986). NB contains twostop–start of translation mechanism (Horvath et al.,
N-terminal sites for the addition of N-linked carbohydrate1990), but the function of the BM2 protein in the influenza
chains (asparagine residues 3 and 7). In influenza B vi-B virus life cycle is unknown. RNA segment 7 of influenza
rus-infected cells after a short pulse-label, the NB protein
can be identified in an unglycosylated form (NB12 , Mr1 To whom correspondence and reprint requests should be ad- 12,000) which becomes modified by the sequential ad-dressed at Department of Biochemistry, Molecular Biology, and Cell
dition of two high mannose carbohydrate chains (identi-Biology, Northwestern University, 2153 North Campus Drive, Evanston,
IL 60208-3500. Fax: (847) 491-2467. E-mail: ralamb@nwu.edu. fied as species NB15 , Mr15,000 and NB18 , Mr18,000).
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Both carbohydrate chains can be further modified by the 15–60% (w/v) sucrose/NTE gradient as described above
and then subsequently purified on a isopycnic densityaddition of multiple lactosaminoglycan (Galb1 r
4GlcNAcb1 r 3), repeating units to generate the hetero- gradient consisting of a 15–60% (w/v) sucrose/D2O/NTE
gradient (SW41 rotor, 30,000g, 17 hr, room temperaturegeneously migrating species NBpl (Mr 20,000–60,000)
(Williams and Lamb, 1986, 1988). The NB protein is abun- (RT)). The banded virus was then diluted 25 times in
NTE, pelleted by centrifugation (40,000g, 1 hr, 47), anddantly expressed at the surface of virus-infected cells
(Shaw and Choppin, 1984; Williams and Lamb, 1986) and resuspended in NTE.
thus it is a candidate glycoprotein to be incorporated into
Metabolic labelingbudding virions.
Early experiments to determine if the M2 protein of For [3H]palmitate labeling, CV1 cells were infected with
influenza A virus is a component of virions were negative. influenza A or B virus (m.o.i.  20 PFU/cell) for 1 hr and
However, as amantadine treatment of virions prevents the inoculum was replaced with DMEM containing 2.5%
virion uncoating and the M2 ion channel is blocked by BSA. At 3 hr p.i. infected cells were labeled for 3 hr
the drug, it became compelling that M2 had to be a com- with [3H]palmitic acid (300 mCi/ml; New England Nuclear
ponent of virions. The development of suitable antibody Research Products, Boston, MA) in DMEM containing 5
reagents and sensitive detection methods indicated that mM sodium pyruvate and 10% tryptose phosphate buffer.
the M2 ion channel is found at 14–68 monomers per For 32P-labeling, virus-infected cells at 5 hr p.i. were incu-
virion. In comparison to the amounts of HA found at the bated for 2 hr with [32P]orthophosphate (500 mCi/ml; ICN,
cell surface and in virions, the M2 protein is greatly under Radiochemicals, Costa Mesa, CA) in phosphate-free
represented in virions (Zebedee and Lamb, 1988). It is DMEM. In parallel, virus-infected cells were labeled with
possible that in the influenza B virus life cycle the NB [35S]cysteine (150 mCi/ml) in DMEM deficient in cysteine.
protein has a similar role to that of M2 in the influenza Labeled cells were solubilized in RIPA buffer and poly-
A virus life cycle. Again, early studies failed to detect NB peptides immunoprecipitated as described previously
in virions (Shaw and Choppin, 1984). However, using (Lamb and Choppin, 1976).
more sensitive methods we wished to reinvestigate if NB
is a component of virions as its presence or absence Polyacrylamide gel electrophoresis, densitometric
would be a first step in unravelling the function of the analysis, and BioImager analysis
protein.
Polypeptides were separated on SDS–PAGE using a
17.5% polyacrylamide gel or a 17.5% polyacrylamide gelMATERIALS AND METHODS
containing 4 M urea and processed for autoradiography
Cells, viruses, and virus purification or fluorography as described previously (Lamb et al.,
1978). Autoradiograms were quantified using a laser den-CV1 and MDCK cells were maintained and infected as
sitometer (LKB UltraScan, Pharmacia, Inc., Piscataway,described previously (Lamb and Choppin, 1976; Lamb et
NJ). In some cases, radioactivity in dried gels was quanti-al., 1978). Influenza A/WSN/33 and B/Lee/40 viruses were
fied using a BioImaging Analyzer and MacBAS softwaregrown in either 10-day-old embryonated chicken eggs
(Fuji Medical Systems, Stamford, CT).and harvested at 72 hr p.i. or the viruses were grown in
MDCK cells and harvested at 48 hr p.i. (Lamb and Chop-
Preparation of anti-NB antibodies and immunoblotting
pin, 1976; Lamb et al., 1978). To obtain [35S]cysteine-
analysis
labeled virus, 10-day-old embryonated chicken eggs
were inoculated with influenza B/Lee/40 virus, incubated A synthetic peptide representing a portion of the C-
terminal domain of the NB protein (residues 58–74) wasat 357 for 24 hr, injected with 150 mCi [35S]cysteine per
egg, and then incubated for an additional 48 hr at 357. coupled to keyhole limpet hemocyanin and rabbit poly-
clonal sera to the conjugated complex was produced asThe allantoic fluid was harvested and clarified by centrif-
ugation (5,000g, 15 min, 47) and the virus pelleted by described previously (Richardson et al., 1985).
To purify NB-specific IgG, NB anti-peptide rabbit poly-centrifugation (40,000g, 1 hr, 47). The virus was resus-
pended in NTE (10 mM Tris–HCl (pH 7.4), 100 mM NaCl, clonal sera was dialyzed against binding buffer (10 mM
NaH2PO4 , pH 7.5, 150 mM NaCl, 10 mM EDTA) and IgGand 1 mM EDTA) and purified by rate zonal density gradi-
ent centrifugation on two successive 15–60% (w/v) su- was affinity purified by using a protein-G column and
eluting with 0.5 M NaOAc, pH 3, buffer at 47. NB-specificcrose/NTE gradients (Lamb and Choppin, 1976). For
quantitative immunoblot analysis, the concentration of IgG was then purified by column chromatography by us-
ing epitope-tagged NB protein (NBNTAG; see below) co-purified virus preparations was determined using a BCA
protein assay reagent (Pierce, Rockford, IL). valently coupled to CNBr-activated Sepharose 4B (Phar-
macia, Piscataway, NJ). The conditions for NB-specificFor immunogold electron microscopy, influenza B/Lee/
40 virus was purified either from allantoic fluid as de- IgG binding to and elution from the NBNTAG protein were
the same as described above for total IgG purification.scribed above or pelleted virus was purified first on a
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For immunoblot analysis, polypeptides separated by terminus of the NB cDNA by PCR (Saiki et al., 1988)
and the modified cDNA (NBNTAG) was subcloned intoSDS–PAGE were electrotransferred to PVDF membrane
(Immobilon P, Millipore Corporation, Bedford, MA) using pBlueBacIII (Invitrogen, San Diego, CA). A recombinant
baculovirus expressing NBNTAG was constructed us-a Trans-Blot SD, Semi-Dry Transfer Cell (Bio-Rad Labora-
tories, Hercules, CA) and transfer buffer (48 mM Tris – ing standard recombinant DNA methodologies (Ausubel
et al., 1994). To purify recombinant NBNTAG protein,HCl, 39 mM glycine, 20% methanol). To prevent nonspe-
cific adsorption of antibody, the membrane was dried at Sf9 cells were infected with the recombinant NBNTAG
baculovirus and the cells harvested 48 – 72 hr p.i. TheRT, hydrated in methanol, and incubated in blocking
buffer (5% powdered milk/0.3% Tween-20/PBS) for either cells were pelleted (5,000g, 15 min, 47) and Dounce
homogenized in a hypotonic buffer (10 mM Hepes, pH1 hr at RT or overnight at 47. The NB-specific C-terminal
peptide rabbit serum, the influenza B/Lee/40 M1-specific 7.7, 1 mM EDTA, 1 mg/ml pepstatin A, 4 mg/ml chymo-
statin, 2 mg/ml leupeptin, 2 mg/ml aprotinin, 50 mg/mlrabbit serum (Horvath et al., 1990), and the influenza
B/Lee/40 HA-specific or influenza B/Lee/40 NA-specific antipain, 10 mM phenylmethylsulfonyl fluoride). The
membranes were collected by centrifugation of the ho-goat polyclonal sera (Research Reference Reagents, Na-
tional Institute of Allergy and Infectious Diseases, mogenate through a 30 and 60% sucrose discontinuous
gradient (80,000g, 16 hr, 47). The membrane interfaceBethesda, MD) were each diluted in blocking buffer and
incubated with the membrane for 1 hr at RT. The second- was collected, diluted in 10 mM Hepes, pH 7.7, 1 mM
EDTA, 10 mM PMSF, and 2 mg/ml aprotinin, and theary antibody was either horseradish peroxidase (HRP)-
conjugated goat anti-rabbit IgG F(ab*)2 (Organon Teknika, membranes were pelleted (175,000g, 30 min, 47). The
membrane pellet was resuspended in 25 mM Hepes,Durham, NC) or horseradish peroxidase-affinipure don-
key anti-goat IgG (Jackson ImmunoResearch Labora- pH 7.7, 1 mM EDTA, 150 mM NaCl, and solubilized
by the addition of octyl glucoside to 1% (Calbiochem-tories, Inc., West Grove, PA) diluted in blocking buffer.
The membrane was washed extensively in PBS/0.3% Novabiochem Corp., La Jolla, CA). Insoluble material
was pelleted by centrifugation (100,000g, 15 min, 47).Tween-20 and antibody complexes were detected using
the enhanced chemiluminescence (ECL) system (Amer- The NBNTAG protein was purified at 47 using a 12CA5
anti-HA MAb (Wilson et al., 1984) immunoaffinity col-sham Life Science, Arlington Heights, IL). For quantitative
immunoblot analysis, the luminescent signal was de- umn. The 12CA5 IgG was coupled to CNBr-activated
Sepharose 4B (Pharmacia, Piscataway, NJ) as recom-tected using preflashed X-ray film (Laskey and Mills,
1975). mended by the manufacturer. To purify NBNTAG, the
12CA5 column was equilibrated prior to use in column
Endoglycosidase treatment buffer (25 mM Hepes, pH 7.7, 1 mM EDTA, 150 mM
NaCl, 1% octylglucoside), and the protein containing su-NB protein immunoprecipitated from influenza B/Lee/
pernatant was loaded at a rate of 0.5 ml/min. The col-40 virus-infected CV1 cell lysates, unlabeled purified viri-
umn was first washed with 10 column volumes of col-ons, or [35S]cysteine-labeled purified virions were incu-
umn buffer and then washed with 10 column volumesbated in the presence of protease inhibitors for 16 hr at
of column buffer with the NaCl concentration adjusted377 with either peptide N-glycosidase F (PNG) (0.6–1 U)
to 500 mM. The bound NBNTAG protein was eluted from(Boehringer Mannheim Corp., Indianapolis, IN) at pH 7.5,
the column with 100 mM glycine, pH 2.5, 500 mM NaCl,or endo b-galactosidase (EndoB) (3–5 mU) (ICN Bio-
1% octylglucoside, and the eluted protein was neutral-chemicals, Costa Mesa, CA) at pH 5.8 as described pre-
ized immediately with one-tenth volume 1 M Tris – HCl,viously (Williams and Lamb, 1986). An equivalent volume
pH 9.0. Column fractions containing purified proteinof protein lysis buffer containing reducing agent (Lamb
were pooled and concentrated using a Centriprep 30et al., 1978) was added and the polypeptides were ana-
concentrator (Amicon Division, W. R. Grace & Co., Bev-lyzed by SDS–PAGE.
erly, MA). The NBNTAG protein preparation was di-
gested with PNG as described above. The purity andProteinase K digestion of purified virions
concentration of the NBNTAG protein was determined
Purified virions from sucrose gradient fractions were by SDS – PAGE analysis on a 17.5 polyacrylamide – 4 M
incubated with proteinase K (200 mg/ml) at 377 for 30 min, urea gel (Lamb et al., 1978). Known amounts of a-lactal-
and the virus was pelleted through a 10% (w/v) sucrose bumin (14.2 kDa) were used as a concentration stan-
cushion (250,000g, 1.6 hr, 47). The virion pellets were dard, and the polypeptides were visualized by silver
resuspended in protein lysis buffer containing reducing stain (Bio-Rad Laboratories, Hercules, CA).
agent and analyzed by immunoblot as described above.
Electron microscopy and immunocytochemistryPurification of the influenza virus NB glycoprotein
To purify the NB protein, an HA epitope tag (YPYDVP- Goat anti-rabbit or anti-mouse IgG coupled to 5-nm
gold particles and donkey anti-goat IgG bound to 10 nmDYA) (Wilson et al., 1984) was engineered at the 5*-
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gold were prepared as described (Slot and Geuze, 1985).
Intact influenza B/Lee/40 virions purified as described
above were prepared for negative staining by diluting
the virions 1:25 in NTE as described previously (Paterson
et al., 1995). Virions were disrupted by floating the grids
face down for 30 sec on drops of either 0.05 or 0.2%
saponin or 0.1% NP-40 diluted in NTE. The staining of
either intact or disrupted virions with antibodies was car-
ried out as described (Paterson et al., 1995). Affinity-
purified rabbit IgG specific for NB was used at a 1:100
dilution and whole goat sera specific for influenza B virus
HA, and ascites fluid containing monoclonal antibody
MAb 14C2 specific for the M2 protein of influenza A virus,
were used at a 1:300 dilution. To show specificity of
the immunogold staining a competition experiment was
performed in which NB-specific IgG was diluted into a
100-fold molar excess of the NB cytoplasmic tail peptide
(residues 58–74) against which the sera was raised and
incubated for 1 hr at RT. As a control the same amount
of NB-specific IgG was diluted into buffer. The antibody
samples were then used to stain virus preparations in
parallel.
RESULTS AND DISCUSSION
Identification and characterization of NB protein in
influenza B virions
To investigate if NB is a component of purified influ-
enza B virus, virions were grown in embryonated chicken
eggs, purified on two consecutive 15–60% sucrose den-
sity gradients, and fractions analyzed on SDS–PAGE.
Silver staining of polypeptides showed peak amounts of
the viral polypeptides HA1 , NA, NP, HA2 , and M in frac-
tions 12 and 13 (Fig. 1A). However, even upon overload-
ing a gel with virion polypeptides, the NB glycoprotein
was not detected by silver staining. Serial immunoblot FIG. 1. Identification of the NB glycoprotein in purified influenza B virus.
analysis of a duplicate gel using antibodies specific for Influenza B/Lee/40 virus was grown in embryonated chicken eggs and
purified on two consecutive 15–60% sucrose density gradients as describedeither the NA or HA (Figs. 1B and 1C, respectively) and
previously (Lamb and Choppin, 1976). Fractions were collected from thecomparison of the gel electrophoretic mobilities of the
bottom of the gradient and each fraction was subjected to SDS–PAGE onpolypeptides verified the identity of the viral proteins.
a 17.5% polyacrylamide–4 M urea gel. (A) Silver-staining of polypeptides
Immunoblotting using an NB-specific antibody (Fig. 1D) contained in gradient fractions 6–17. (B) Immunoblot analysis of a duplicate
showed that a NB immunoreactive species could be gel to that shown in (A). The polypeptides were electrotransferred to a
PVDF membrane and the membrane was probed with a goat polyclonalfound in predominantly the same gradient fractions as
sera specific for influenza B virus neuraminidase (NA). A donkey anti-goatthe other virion polypeptides (fractions 12 and 13). NB
HRP-conjugated secondary antibody and the ECL (enhanced chemilumines-was found in virions as two species, NBc (Mr 10,000), cence) system were used. Only the relevant portion of the X-ray film is
and as a heterogeneously migrating species, NBpl (Mr shown. (C) The same immunoblot as in (B) was stripped and reprobed
25,000–60,000), a mobility which is consistent with ad- using a goat polyclonal sera specific for the influenza B virus hemagglutinin
(HA). Only the relevant portion of the X-ray film is shown. (D) The samedition of polylactosaminoglycan to NB. In some batches
immunoblot as in (B) and (C) was stripped and reprobed using a rabbitof virions, the NBpl species showed a tighter mobility
polyclonal sera specific for the NB protein. A goat anti-rabbit HRP-conju-(Mr 45,000) (Fig. 1D). Variation in the amount of NBpl gated secondary antibody and the ECL system was used to visualize NB.
contained in virion preparations grown in eggs is be- See the text for a discussion concerning the band found in almost all
lieved to reflect a difficulty in transferring the highly glyco- gradient fractions that migrates near the top of the gel.
sylated species to the membrane for immunoblotting.
The identity of the polypeptide species found in all frac- contaminant introduced in the immunoblot procedure
that is recognized by the rabbit sera.tions of the gradient that migrates near the top of the gel
is unknown: it seems likely that it is a human polypeptide The glycosylated status of the NB protein species
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treatment of cell surfaces with proteinase K to yield a
species of Mr 10,000 (Williams and Lamb, 1986). Thus,
to investigate further the nature of NBc , virions grown in
MDCK cells were digested with proteinase K and poly-
peptides analyzed by SDS–PAGE and immunoblot. As
shown in Fig. 3A, proteinase K digestion of virions
caused a loss of NBpl with a concomitant increase in the
amount of two NBc species which had the same gel
mobility as those found in egg grown virus. To show that
proteinase K treatment did not greatly compromise the
integrity of the virion envelope, an immunoblot of the
proteinase K-sensitive internal protein, M1 , was per-
FIG. 2. Analysis of glycosylation of NB glycoprotein in purified influ-
enza B virus. Virus grown in either embryonated chicken eggs or MDCK
cells was purified on two consecutive sucrose density gradients and
digested with either PNG or EndoB as described under Materials and
Methods. The polypeptide species were separated on a 17.5% poly-
acrylamide– 4 M urea gel and electrotransferred to PVDF membrane.
Immunoblotting for NB was performed as described under Materials
and Methods. Molecular weight markers (1103) are indicated.
found in virions was confirmed by digesting purified viri-
ons with either PNG or EndoB (Fig. 2). PNG removes
high mannose and complex carbohydrate chains from
polypeptides and EndoB is specific for the b1 r 4 linkage
of the (Galb1 r 4GlcNAcb1 r 3) lactosamine repeating
unit, reducing a polylactosamine moiety to its high man-
nose core. Polypeptides were analyzed by SDS–PAGE
and immunoblot analysis. Digestion of glycosylated NB
with PNG reduced all forms of NB to NB12 with the excep-
tion of species NBc . It was observed that EndoB digestion
of virions, grown in MDCK cells or eggs, converted the
heterogeneously migrating NB species (NBpl) to NB18
(Fig. 2), thus providing direct evidence that NBpl is modi-
fied by polylactosaminoglycan (Fukuda et al., 1984; Wil-
liams and Lamb, 1988). The species NBc migrated with
FIG. 3. Loss of the NB N-terminal region by proteolysis. Virions grown
a faster mobility than unglycosylated NB12 and was only in MDCK cells or eggs were purified on two consecutive sucrose den-
observed in purified virions and not virus-infected cells sity gradients. MDCK cell grown virions were digested with proteinase
(data not shown). Since this species was unaffected by K. Egg grown virions were digested with either PNG or EndoB as
described under Materials and Methods. The polypeptide species wereglycosidase treatments, it suggests that NBc lacks a por-
separated on a 17.5% polyacrylamide–4 M urea gel and electrotransfer-tion of the N-terminal ectodomain containing the sites
red to a PVDF membrane. (A) The membrane was probed with a rabbit
for carbohydrate addition. Not only was a greater amount polyclonal sera specific for NB protein as described under Materials
of NBc observed in egg grown virus in comparison to and Methods. Molecular weight markers (1103) are indicated. (B) The
MDCK grown virus, but two NBc species of very similar same immunoblot as in (A) was stripped and reprobed using a rabbit
polyclonal sera specific for the M1 protein. Only the relevant portiongel mobility were found in egg grown virus while virus
of the blot is shown. The antibody recognition of NBp1 is seeminglygrown in MDCK cells contained only one NBc species.
interrupted at Mr 22,000 by a band of nonstaining material. This band
was observed reproducibly and it is not an artifact of the membraneProtease cleavage of the NB ectodomain
or electrotransfer apparatus. The exclusion of staining in this region
It has been shown previously that NB expressed at of the blot is thought to be due to an unknown molecule that migrated
on the gel and transferred to the membrane.the surface of cells can be proteolytically trimmed by
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formed (Fig. 3B). The loss of M1 protein was small and ogy of the virions was observed by EM. A representative
field of intact untreated virion particles at low magnifica-is probably due to technical manipulations of virions.
Thus, the data indicate that proteinase K digestion of tion is shown in Fig. 4A. Upon disruption of virions with
saponin (Figs. 4B and 4C), a great change in the morphol-virions removes an N-terminal domain. The loss of the
NB N-terminal ectodomain on some of the NB molecules ogy of the virions occurred as the membrane was dis-
rupted and large diffuse structures were observed. Thewhen the virus is grown in eggs is probably due to a
protease present in the allantoic fluid such as a factor extent of disruption was dependent upon the concentra-
tion of glycoside used (Fig. 4B, 0.05% saponin; Fig. 4C,Xa-like activity (Gotoh et al., 1992a, 1990, 1992b). Interest-
ingly, there is a parallel to the data reported here for NB, 0.2% saponin) and it occurred sufficiently frequently that
the dilated structures could only arise from disruptedas the virion-associated M2 protein of influenza A/PR/8/
34 and A/WS/1/33 when virions are grown in eggs con- virions. Thus, the possibility that the preparation con-
tained contaminating vesicles that were being misidenti-tains a cleaved ectodomain (Panayotov and Schlesinger,
1992). fied as disrupted virions was eliminated. Furthermore,
the use of the detergent NP-40, severely altered the struc-
ture of the viral particles visualized by negative stainingIdentification of the NB protein in purified influenza B
(Fig. 4D) with the remaining structures present as clumpsvirus using immunogold labeling and electron
of presumably protein and RNA, apparently devoid ofmicroscopy
membrane. The NP-40 treatment also stripped some of
the virions from the grid.To show further that NB is a component of the influ-
enza B/Lee/40 virion we performed immunogold electron When intact virions were stained with the NB-specific
IgG (Fig. 5A), little or no surface staining was observedmicroscopy (EM) on purified virions. To minimize the pos-
sibility of membrane vesicles contaminating the virus when using the C-terminal site-specific sera which is con-
sistent with the known orientation of NB in membranes.preparation, an isopycnic density equilibrium gradient
was incorporated into the purification scheme. As de- Further, the absence of signal was not due to an inability
to stain the viral surface proteins as shown by the stainingscribed under Materials and Methods, influenza B/Lee/
40 virus was grown in embryonated chicken eggs, puri- of HA in intact viruses using a HA-specific goat polyclonal
antiserum (Fig. 5B). To expose the NB cytoplasmic tailfied first by rate zonal centrifugation, and subsequently
purified by isopycnic density equilibrium centrifugation epitope to the NB-specific IgG, the virions were disrupted
by using 0.05% saponin and, as shown in examples inon a 15–60% (w/v) sucrose/D2O/NTE gradient. The den-
sity of the banded virus used for EM was 1.23 g/cc. Figs. 5C–5E, immunogold-staining for NB could be readily
detected. The specificity of the NB IgG staining was con-Immunoblot analysis of the amount of NB contained in
the isopycnic density gradient purified virus showed the firmed by preincubating NB IgG with an excess of the
peptide (NB residues 58–74) against which the sera wassame relative amount of NB in these virion preparations
as that obtained in virions purified using rate zonal den- raised and staining was reduced by 70–80% (Fig. 5F).
While a higher percentage of competition might have beensity gradient centrifugation and used for the biochemical
analysis (see Fig. 1). expected, the affinity of the IgG for the peptide is unknown,
and a low affinity could account for a lessened degreeFor EM immunocytochemical staining of NB protein, it
would be ideal to have available an N-terminal ectodo- of competition. Almost no staining was observed when
disrupted virions were stained with the secondary gold-main-specific sera. However, site-specific peptide sera
raised to the NB N-terminal domain only recognized un- coupled antibody alone (data not shown) or with an irrele-
vant primary antibody, the influenza A virus M2 protein-glycosylated or deglycosylated NB (Williams and Lamb,
1988) and thus could not be used on intact virions. Thus, specific 14C2 MAb (Fig. 5G). When virions were treated
with 0.1% NP-40 and then stained with NB-specific IgG,we turned our attention to a C-terminal cytoplasmic tail
peptide sera raised to NB residues 58–74. The NB cyto- the amount of staining was typically greater than that ob-
served for saponin-treated samples, suggesting that theplasmic tail peptide sera was affinity purified using im-
mobilized epitope-tagged NB protein, NBNTAG (see Ma- more extensive disruption caused by NP-40 either allowed
for better penetration of antibodies or exposed more epi-terials and Methods), and the NB-specific IgG recognized
the NB protein in both immunoprecipitation experiments topes to antibody binding. Despite the apparent absence
of visible membrane in NP-40-treated virions a largeand indirect immunofluorescent staining of permeabil-
ized influenza B/Lee/40 virus-infected CV1 cells (data not amount of HA remained as shown by staining with HA-
specific antiserum (Fig. 5I). Similar preparations stainedshown). To use the NB cytoplasmic tail peptide-specific
IgG for EM immunostaining, disruption of the viral enve- with either the rabbit (Fig. 5J) or goat (data not shown)
specific gold-coupled secondary antibodies exhibited lowlope was necessary for the IgG to gain access to the
epitope. Virions were disrupted by using either the plant background staining. Thus, the presence of NB glycopro-
tein in purified virions was demonstrated by EM immuno-glycoside saponin or NP-40 detergent followed by nega-
tive staining with phosphotungstic acid and the morphol- cytochemistry.
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FIG. 4. Disruption of influenza B/Lee/40 virus with either saponin or NP-40. Purified influenza virus was prepared for electron microscopy as
described under Materials and Methods. Negative staining with phosphotungstic acid of either untreated (A), 0.05% saponin and 0.2% saponin
treated (B and C, respectively), and 0.1% NP-40 treated virus samples (D). Bar, 0.25 mM.
Quantification of amount of NB protein in virions in an influenza B virion is equal to the approximate numbers
calculated for each counterpart polypeptide present in a
The amount of NB protein present in influenza B virions spherical influenza A virion (HA  500–1,200, NA  100–
was investigated using two approaches: the direct labeling 200, M1  2300–3000, and NP  500–800 molecules/
of viral proteins, allowing densitometric and BioImager virion) (Compans et al., 1970; Inglis et al., 1976; Skehel and
analysis, and a quantitative immunoblot analysis standard- Schild, 1971) then there are between 15 and 100 molecules
ized with purified NB protein. First, influenza B/Lee/40 virus of NB present in an influenza B virion. The highest number
was grown in embryonated chicken eggs in the presence (100) of molecules of NB present per virion was obtained
of [35S]cysteine and purified as described under Materials using the values for M1 (3000 molecules/virion). The lowest
and Methods. In three separate experiments, purified virus number (15) of molecules of NB present per virion was
was digested with either PNG or EndoB to convert NBpl to obtained using the NA and HA values (100 and 500 mole-
NB12 or NB18 , respectively. As gel markers, [
35S]cysteine- cules/virion, respectively). Thus, the wide range of values
labeled influenza B virus-infected cell lysate was immuno- calculated for the amount of NB present in an influenza B
precipitated with antibody specific for the NB protein (either virion represents not only the wide range of values for HA,
mock, PNG, or EndoB treated). A representative gel is NA, M1 , and NP reported in the literature but also a possibly
shown in Fig. 6A. Both densitometric and BioImaging analy- incorrect assumption about the equality of influenza A and
sis indicated the presence of NB18 on treatment with EndoB influenza B viral proteins present in the virion.
and NB12 on treatment with PNG. Quantification of the The second method of quantifying the amount of NB
amount of NB protein present in virions with respect to the in virions required purified NB protein as a standard for
amount of the other virion polypeptides was performed. an immunoblot. To facilitate purification of NB, a HA epi-
The number of cysteine residues present in each protein tope tag (YPYDVPDYA) (Wilson et al., 1984) was engi-
was determined from their known sequence and the rela- neered into the NB cDNA such that the modified NB
tive number of moles of each protein present in an influenza protein (NBNTAG) contained an N-terminal tag and a
B virion calculated. If the assumption is made that the recombinant baculovirus was constructed. NBNTAG was
purified from recombinant baculovirus-infected Sf9 cellsnumber of molecules of HA1 , HA2, NA, M1 , and NP present
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FIG. 5. Immunogold electron microscopic experiments identify NB as a component of the influenza B/Lee/40 virion. Intact virions were either stained with
NB IgG (A) or B/Lee/40 HA antisera (B) and visualized with secondary antibodies conjugated to 5 and 10 nm gold, respectively, as described under Materials
and Methods. Upon disruption of virions with 0.05% saponin (C, D, E, F, and G) a bloated structure was observed, and NB staining (C, D, and E) is shown.
Arrowheads point to 5 nm gold particles while arrows point to viral membrane-associated spikes. The NB-specific staining was blocked by pretreatment of
the IgG with the peptide epitope to which the sera was raised (F) and control experiments with the MAb 14C2, specific for the influenza A M2 protein,
showed no labeling (G). Upon treatment of viral particles with NP-40 a severely altered structure was observed (H, I, and J) which showed no labeling when
stained with goat-anti-rabbit secondary alone (J), but showed a level of staining well above background in NB IgG stained virus (H). NP-40-treated virus
stained with B/Lee/40 HA antisera and visualized with secondary antibodies conjugated to 10 nm gold (I) showed a specific reaction. Bar, 100 nm.
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using an anti-HA MAb (12CA5) (Wilson et al., 1984) immu-
noaffinity column as described under Materials and
Methods. While the purified protein was found to be gly-
cosylated (both high mannose and polylactosamine mod-
ified; data not shown), the majority of purified NBNTAG
was found as a deglycosylated species (Mr 15,000).
Possibly the glycosylated forms of NBNTAG were not
purified efficiently using the MAb affinity column (data not
shown), presumably because the carbohydrate moieties
sterically hinder accessibility to the antibody epitope.
To facilitate immunoblot quantification, the purified
protein was digested with PNG. The concentration of
the PNG-digested NBNTAG protein was determined by
coelectrophoresing concentration standards of a-lactal-
bumin (Mr 14,200) and measuring the intensity of silver
stain by densitometry (data not shown). In an immunoblot
assay known amounts of NBNTAG protein (2, 2.5, 5, 10
ng) were used to generate a densitometric standard
curve which permitted the quantification of the amount
of NB protein present in known amounts (2.4, 4.8, 9.6
mg) of purified influenza B/Lee/40 virions (Fig. 6B). If the
assumption is made that the molecular mass of a virion
is 2.1 1 108 (Inglis et al., 1976) and the molecular weight
of NB is 12,737 (Shaw et al., 1982), it can be calculated
that there are 15 molecules of NB per influenza B virion.
These data indicate that the numerical values obtained
using the two methods are in reasonable agreement and
thus NB is a minor component of influenza B virus. Al-
though the number of NB molecules incorporated on av-
erage into an influenza B virus particle is small, thisFIG. 6. Quantification of the amount of NB protein found in influ-
enza B virions. (A) Direct analysis of [35S]cysteine-labeled influenza finding is reminiscent of the average number of mole-
B/Lee/40 virions grown in embryonated chicken eggs. Virions were cules (14–68 monomers) found in each influenza A virion
purified on two consecutive sucrose density gradients and digested
of the essential M2 ion channel protein (Zebedee andwith either PNG or EndoB as described under Materials and Meth-
Lamb, 1988).ods. The polypeptide species were separated on a 17.5% polyacryl-
amide – 4 M urea gel, and the gel was exposed to X-ray film and
quantified as described under Materials and Methods. As gel mark- Metabolic labeling of influenza B virus-infected cells
ers, influenza B virus-infected CV-1 cells were labeled with [35S]-
with [32P]orthophosphate and [3H]palmitic acidcysteine from 6 to 8 hr p.i.; NB was immunoprecipitated with a NB-
specific antisera and treated with either PNG or EndoB as described
Influenza A virus M2 protein is posttranslationally modifiedunder Materials and Methods. The mock lane represents a virus
by addition of palmitate to cysteine residue 50 (Holsingersample identical to those that were treated with PNG or EndoB but
incubated at 377 without addition of enzyme. The arrowheads indi- et al., 1995; Sugrue et al., 1990; Sugrue and Hay, 1991; Veit
cate the NB18 species formed upon EndoB digestion, and NB12 spe- et al., 1991) and is modified by phosphorylation at serine
cies formed upon PNG digestion. (B) Immunoblot analysis comparing
residue 64 (Holsinger et al., 1995). NB contains four cyto-the amount of NB protein found in purified influenza B/Lee/40 virus
plasmic cysteine residues and three cytoplasmic serine andto a known concentration of purified NBNTAG protein. Baculovirus-
three cytoplasmic threonine residues. To determine if theexpressed NBNTAG was purified on an HA MAb immunoaffinity col-
umn and the concentration of purified protein was determined as NB protein is posttranslationally modified by the addition of
described under Materials and Methods. Dilutions of purified em- palmitic acid or phosphate, influenza virus B/Lee/40 virus-
bryonated chicken egg grown virus (2.4, 4.8, 9.6 mg) and NBNTAG
infected CV1 cells were metabolically labeled with eitherprotein (2, 2.5, 5.0, 10 ng) were separated on the same 17.5% poly-
[3H]palmitic acid or [32P]orthophosphate. Infected cell ly-acrylamide – 4 M urea gel and electrotransferred to a PVDF mem-
sates were immunoprecipitated with NB-specific antiserabrane. The membrane was probed with a rabbit polyclonal sera
specific for the NB protein and antibody detected using the ECL and analyzed by SDS–PAGE. As a positive control, influenza
system. Densitometric quantification of the amount of NB protein A virus-infected CV1 cells were labeled in parallel with either
detected in influenza B virions was performed as described under
[3H]palmitic acid or [32P]-orthophosphate and M2 proteinMaterials and Methods. The relevant portion of the gel containing
was immunoprecipitated using a M2-specific MAb 14C2the NB protein is shown. The unlabeled NBNTAG species are glyco-
(Zebedee and Lamb, 1988). For both the [3H]palmitic acidsylated forms of NBNTAG which were not included in the final deter-
mination of protein concentration. and [32P]orthophosphate labeling procedures, duplicate
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a component of the virion. Thus, NB is the third influenza
B virus integral membrane protein found in the virion.
Our studies indicate there are, on average, approximately
15 to 100 molecules of NB per influenza B virus particle
and these NB molecules exist in two forms, either modi-
fied by addition of polylactosaminoglycan or in a form
where the NB ectodomain is cleaved to yield an unglyco-
sylated species, NBc .
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